These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26205378)

  • 1. A Small-Molecule Probe for Selective Profiling and Imaging of Monoamine Oxidase B Activities in Models of Parkinson's Disease.
    Li L; Zhang CW; Ge J; Qian L; Chai BH; Zhu Q; Lee JS; Lim KL; Yao SQ
    Angew Chem Int Ed Engl; 2015 Sep; 54(37):10821-5. PubMed ID: 26205378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson's disease models.
    Li L; Zhang CW; Chen GY; Zhu B; Chai C; Xu QH; Tan EK; Zhu Q; Lim KL; Yao SQ
    Nat Commun; 2014; 5():3276. PubMed ID: 24522637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease.
    Park HR; Kim J; Kim T; Jo S; Yeom M; Moon B; Choo IH; Lee J; Lim EJ; Park KD; Min SJ; Nam G; Keum G; Lee CJ; Choo H
    Bioorg Med Chem; 2013 Sep; 21(17):5480-7. PubMed ID: 23810676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
    Chung JY; Lee JW; Ryu CH; Min HK; Yoon YJ; Lim MJ; Park CH
    J Neurosci Res; 2015 Aug; 93(8):1267-78. PubMed ID: 25711470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.
    Unzeta M; Sanz E
    Int Rev Neurobiol; 2011; 100():217-36. PubMed ID: 21971010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurochemical perspectives of the function of monoamine oxidases].
    Riederer P; Konradi C; Hebenstreit G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():7-10. PubMed ID: 2685857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Strategy for Specific Fluorescence Imaging of Monoamine Oxidase A in Living Cells.
    Wu X; Shi W; Li X; Ma H
    Angew Chem Int Ed Engl; 2017 Nov; 56(48):15319-15323. PubMed ID: 29027345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
    Rojas RJ; Edmondson DE; Almos T; Scott R; Massari ME
    Bioorg Med Chem; 2015 Feb; 23(4):770-8. PubMed ID: 25600407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
    Prins LH; Petzer JP; Malan SF
    Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected chromone derivatives as inhibitors of monoamine oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
    Bainbridge JL; Page RL; Ruscin JM
    Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E; Chodera A
    Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive and Selective Ratiometric Fluorescence Probes for Detection of Intracellular Endogenous Monoamine Oxidase A.
    Wu X; Li L; Shi W; Gong Q; Li X; Ma H
    Anal Chem; 2016 Jan; 88(2):1440-6. PubMed ID: 26652905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of a monoamine oxidase B allele with Parkinson's disease.
    Kurth JH; Kurth MC; Poduslo SE; Schwankhaus JD
    Ann Neurol; 1993 Apr; 33(4):368-72. PubMed ID: 8489207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase B activatable red fluorescence probe for bioimaging in cells and zebrafish.
    Yang Z; Zhong T; Mo Q; He J; Chong J; Hu X; Zhao S; Qin J
    Bioorg Chem; 2024 Apr; 145():107156. PubMed ID: 38387393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial-Targeted and Near-Infrared Fluorescence Probe for Bioimaging and Evaluating Monoamine Oxidase A Activity in Hepatic Fibrosis.
    Yang ZM; Mo QY; He JM; Mo DL; Li J; Chen H; Zhao SL; Qin JK
    ACS Sens; 2020 Apr; 5(4):943-951. PubMed ID: 32223138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
    Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
    Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.